Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
liver enzyme alterations are very frequent in PAC treated patients, even at routine dosage
A mutation in the FMO3 gene affects the FMO3 enzyme
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity
Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le Shay N, Nezhat CN, Kempson R, Lessey BA, Nayak NR, Giudice LC (2006) Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women
thus, whether these immunotherapies will actually provide long-term benefits for patients with p53 mutations remains unclear
Diabetic Medicine, 29 (12), 1475-1481
US$ 26.49
US$ 29.93
US$ 20.40
US$ 28.88
US$ 23.64
US$ 27.78
